| Financial Year |
March 31 2023 |
| Monetary Funds |
508,629,993.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,110.00 |
| Accounts Receivable |
122,738,903.10 |
| Advances to Suppliers |
23,969,688.11 |
| Other Receivables |
4,865,847.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
180,650,756.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,706,359.75 |
| Total Current Assets |
949,339,101.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
309,229,068.84 |
| Investment Properties |
-- |
| Fixed Assetes |
135,822,040.19 |
| Under-construction Projects |
249,729,884.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
52,428,360.14 |
| R&D expenses |
49,232,136.87 |
| Goodwill |
174,347.75 |
| Long-Term Deferred and Prepaid Expenses |
73,572,187.59 |
| Deferred Income Tax Assets |
1,748,656.19 |
| Other Non-Current Assets |
11,766,638.39 |
| Sub-Total of Non-Current Assets |
1,003,814,370.11 |
| Total Assets |
1,953,153,471.58 |
| Short-Term Loans |
125,702,392.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
403,644.06 |
| Accounts Payable |
158,392,927.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,998,436.54 |
| Taxes Payable |
1,219,981.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
635,470,266.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,497,172.05 |
| Other Current Liabilities |
5,994,514.53 |
| Sub-Total of Current Liabilities |
962,032,526.50 |
| Long-term Loans |
458,950,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,795,478.39 |
| Deferred Income Tax Liabilities |
19,356,790.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
602,098,333.62 |
| Total Liabilities |
1,564,130,860.12 |
| Paid-In Capital(Or Share Stock) |
171,700,254.00 |
| Capital Surplus |
597,518,069.31 |
| Surplus Reserve |
35,807,937.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-461,104,109.59 |
| Minority Stockholder's Interest |
45,100,459.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
343,922,151.50 |
| Owner's Equity（Stockholder's Equity） |
389,022,611.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,953,153,471.58 |
